Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px
Organisation › Details

Medac Gesellschaft für klinische Spezialpräparate mbH

medac Gesellschaft fuer klinische Spezialpraeparate GmbH is a privately owned, global pharmaceutical company specialized in the development, manufacturing and marketing of highly-effective therapeutic and innovative diagnostic products in core areas including oncology, urological and autoimmune diseases. Beside an already established product portfolio, medac is dedicated to the refining of existing and the development of new therapeutic products providing patients with groundbreaking individualized treatments. Founded in 1970, medac today employs 1.000 people in its headquarters in Wedel near Hamburg, Germany. *

 

Period Start 1970-01-01 established
Products Industry cancer drug
  Industry 2 cancer test
Person Person Stolberg, Nikolaus Graf (Medac 201703 Managing Director)
     
Region Region Wedel
  Country Germany
  Street 6 Theaterstr.
  City 22880 Wedel
  Tel +49-4103-8006-0
    Address record changed: 2018-07-24
     
Basic data Employees E: 501 to 1,000 (2017-03-16)
     
    * Document for �About Section�: Cevec Pharmaceuticals GmbH. (3/16/17). "Press Release: Cevec, Medac and Provecs Medical Enter into Far-reaching Adenoviral Vector Collaboration in Oncology". Cologne, Wedel & Hamburg.
     
   
Record changed: 2017-09-29

Advertisement

Picture [iito] – Putting Information into Context 600x60px

More documents for Medac Gesellschaft für klinische Spezialpräparate mbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px




» top